2019
Plasma neurofilament light associates with Alzheimer’s disease metabolic decline in amyloid-positive individuals.
Authors:
Benedet, AL.*, Ashton, NJ., Pascoal, TA.*, Leuzy, A., Mathotaarachchi, S.*, Kang, MS., Therriault, J.*, Savard, M.*, Chamoun, M., Scholl, M., Zimmer, ER., Gauthier, S.**, Labbe, A.*, Zetterberg, H., Blennow, K., Neto, PR**.
Journal:
Alzheimer's & dementia : diagnosis, assessment & disease monitoring
Share
Receive the
latest news
Stay updated with the latest research developments from CCNA-CCNV. Our news section provides insights into cutting-edge studies, advancements in dementia care, and key findings in brain health research.
